Abciximab in Emergent Stroke Treatment Trial - II
Phase of Trial: Phase III
Latest Information Update: 01 Dec 2008
At a glance
- Drugs Abciximab (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions; Registrational; Therapeutic Use
- Acronyms AbESTT-II
- 01 Dec 2008 Results published in Stroke.
- 01 Jan 2008 Results have been published.
- 21 Oct 2005 New trial record.